1-BENZYL-8-TERT.-BUTYL-1H,3H-PYRIDO-[2,1-F]-PURINE-2,4-DIONE
Compound with spectra: 1 NMR
![1-BENZYL-8-TERT.-BUTYL-1H,3H-PYRIDO-[2,1-F]-PURINE-2,4-DIONE](/api/compound/FpD6v29DAcr.png?ph=true&h=300&w=458 "1-BENZYL-8-TERT.-BUTYL-1H,3H-PYRIDO-[2,1-F]-PURINE-2,4-DIONE")
| SpectraBase Compound ID | FpD6v29DAcr |
|---|---|
| InChI | InChI=1S/C20H20N4O2/c1-20(2,3)14-9-10-23-15(11-14)21-17-16(23)18(25)22-19(26)24(17)12-13-7-5-4-6-8-13/h4-11H,12H2,1-3H3,(H,22,25,26) |
| InChIKey | OKOSYWZSCFVGIP-UHFFFAOYSA-N |
| Mol Weight | 348.41 g/mol |
| Molecular Formula | C20H20N4O2 |
| Exact Mass | 348.158626 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-BENZYL-8-PHENYL-1H,3H-PYRIDO-[2,1-F]-PURINE-2,4-DIONE
1-BENZYL-8-METHOXY-1H,3H-PYRIDO-[2,1-F]-PURINE-2,4-DIONE
7-(4-Fluoro-phenyl)-1,3-dimethyl-oxazolo[2,3-f]purine-2,4(1H,3H)-dione
7-(3-chlorobenzyl)-1,3-dimethyl-8-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]-3,7-dihydro-1H-purine-2,6-dione
8-{[benzyl(methyl)amino]methyl}-1,3-dimethyl-7-(1-methyl-2-oxopropyl)-3,7-dihydro-1H-purine-2,6-dione
Propanamide, 3-[[7-[(2,6-dichlorophenyl)methyl]-2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl]thio]-N-(3,4-dimethylphenyl)-
L-VALINE-3-[8-[(E)-2-(3-METHOXYPHENYL)-ETHENYL]-7-METHYL-1-PROPARGYLXANTHIN-3-YL]-PROPYLESTER
L-VALINE-3-[8-[(E)-2-(3-ETHOXYPHENYL)-ETHENYL]-7-METHYL-1-PROPARGYLXANTHIN-3-YL]-PROPYLESTER-HYDROCHLORIDE
8-[(4-benzyl-1-piperazinyl)methyl]-7-(2-chloro-6-fluorobenzyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3-Dimethyl-7-propyl-8-[(1-deoxy-2,3:4,5-di-O-isopropylidenexylitol-1-ylimino)methyl]-3,7-dihydro-purine-2,6-dione
| Title | Journal or Book | Year |
|---|---|---|
| Pyrido[2,1-f]purine-2,4-dione Derivatives as a Novel Class of Highly Potent Human A3 Adenosine Receptor Antagonists | Journal of Medicinal Chemistry | 2002 |